세계의 신규 약물전달 시스템(NDDS) 시장

Global Novel Drug Delivery Systems (NDDS) Market to Reach US$65.5 Billion by 2030

The global market for Novel Drug Delivery Systems (NDDS) estimated at US$16.3 Billion in the year 2023, is expected to reach US$65.5 Billion by 2030, growing at a CAGR of 21.9% over the analysis period 2023-2030. Nanoparticles for NDDS, one of the segments analyzed in the report, is expected to record a 21.4% CAGR and reach US$51.9 Billion by the end of the analysis period. Growth in the Embolization Particles for NDDS segment is estimated at 24.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.7 Billion While China is Forecast to Grow at 26.6% CAGR

The Novel Drug Delivery Systems (NDDS) market in the U.S. is estimated at US$5.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$7.4 Billion by the year 2030 trailing a CAGR of 26.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.9% and 19.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 20.3% CAGR.

Global Novel Drug Delivery Systems (NDDS) Market - Key Trends and Drivers Summarized

Novel Drug Delivery Systems (NDDS) refer to innovative methods for delivering medication to patients in a manner that increases the efficacy, safety, and patient compliance with the treatment regimen. These systems are designed to target the delivery of drugs directly to a specific site in the body, control the rate of drug release, and maximize the therapeutic index while minimizing side effects. NDDS encompasses a variety of delivery platforms including liposomes, nanoparticles, microneedles, and drug-eluting stents, among others. These technologies enable controlled and sustained release of medications, potentially reducing dosage frequency and improving patient outcomes. This field is particularly significant in the treatment of chronic diseases, cancer, and for the delivery of vaccines.

The development of NDDS continues to grow as researchers and pharmaceutical companies aim to overcome the limitations of conventional drug delivery methods. One of the key challenges in traditional pharmacotherapy is achieving optimal therapeutic levels of a drug without causing adverse effects, a task that NDDS aims to simplify through advanced formulation and engineering techniques. Enhanced permeability and retention (EPR) effect of nanoparticles, for example, allows for targeted drug delivery to tumor cells, minimizing the impact on healthy tissues and reducing side effects in cancer treatments. Moreover, the application of biodegradable materials in NDDS promotes safer and more effective drug delivery mechanisms, aligning with the growing demand for sustainable medical practices. Additionally, the integration of digital technology into drug delivery systems, such as smart pills equipped with sensors, provides real-time data on drug release and patient adherence, which can be critical for treatments requiring precise dosages.

The growth in the Novel Drug Delivery Systems market is driven by several factors including technological advancements in material science and biotechnology, increasing prevalence of chronic diseases, and a more informed consumer base demanding better and more tailored healthcare solutions. Advancements in nanotechnology and molecular biology have been particularly instrumental in developing more efficient drug delivery systems. These innovations allow drugs to be encapsulated in biocompatible materials that can bypass the body's natural barriers and release drugs at a controlled rate directly at the disease site. Additionally, the rising incidence of chronic conditions such as diabetes and heart disease fuels the demand for more efficient and convenient drug delivery methods, encouraging further investment in NDDS research and development. Lastly, as patients become more engaged in their health care decisions, there is a growing demand for drug delivery systems that are not only effective but also non-invasive and convenient, steering the market towards sustained growth and innovation.

Select Competitors (Total 238 Featured) -

• Alexza Pharmaceuticals
• Ademtech SA
• Acerus Pharmaceuticals Corporation
• Adocia
• Aerogen
• Aktivax, Inc.
• 2C Tech
• Acuitas Therapeutics
• Applied Nanoparticles
• Apogee Technology, Inc.
• 20Med Therapeutics
• AnTolRx Inc.
• Adipo Therapeutic
• AcelRx Pharmaceuticals
• Advanced NanoTherapies Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Novel Drug Delivery Systems (NDDS) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Novel Drug Delivery System (NDDS): A Prelude
  • Versatile Benefits of NDDS Drive Companies to Embrace the Drug Delivery Approach
  • Patient Compliance: A Key Reason Garnering Interest in NDD
  • Regulatory Process for Novel Drug Delivery Systems
  • A Look into Current Areas of Research in Drug Delivery
  • Market Outlook
  • Nanotechnology-Enabled Drug Delivery: Primary Challenges
  • Recent Market Activity
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Nanotechnology Bolsters Demand for NDDS
  • Prospects Remain Encouraging
  • Microfluidics Mediated NDDS Set to Make Gains
  • Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
  • Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
  • List of Marketed Liposome-Based Clinical Products Classified by Therapeutic Areas
  • Liposomes-based Drug Delivery Systems to touch Diverse Areas of Modern Medicine
  • Dendrimers as Ideal Drug Delivery Agents
  • List of Commercially Available Dendrimeric Products by Application Area
  • High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
  • Oral Thin Films Enhance NDDS Domain
  • Nanotechnology-Enabled Drug Delivery Opens New Horizons to Improve Cancer Treatments
  • Rising Cancer Incidence Drives Focus onto Novel Drug Delivery Mechanisms
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Number of New Cancer Cases and Deaths (in Million) by Region for 2020
  • Global Breakdown of Total Number of Cancer Cases by Type: 2020
  • Novel Drug Delivery System Emerges as a Potential Treatment for Pediatric Brain Tumors
  • Uptrend in Gene Therapy Market Augurs Well for Market Growth
  • Global Gene Therapy Market in US$ Million: 2020, 20223 and 2024
  • Adeno-Associated Virus Vectors: A Leading Platform for Gene Therapy
  • Application of Nanotechnology-based Drug Delivery Systems for CVD Treatment
  • Global Annual Medical Cost of CVD in US$ Billion (2020-2030)
  • NDD for Antimicrobial Drugs
  • List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
  • Nanotechnology Opens New Avenues in Antiretroviral Therapy
  • Demonstrated Activity of Select Nanotechnology-Delivered Antiretroviral Therapies
  • Novel Drug Delivery System Exhibits Potential to Target HIV Reservoirs
  • Global HIV Prevalence Seeks Need for Novel Drug Delivery Systems: Number of People Living with AIDs (in Thousands) by Region
  • Novel Drug Delivery Systems for CNS Therapeutics
  • Novel Drug and a New Delivery Method for Restoring Brain Cells in People Suffering from PD
  • Nanotechnology Powers Next Wave of Change for Neglected Tropical Diseases' Treatment
  • Novel Drug Delivery Systems Hold Edge over Existing Therapies for Diabetic Retinopathy
  • Exciting Immunology Developments Involving Graphene-based Nanomaterials
  • Nanotechnology-Based Strategies for siRNA Grows in Popularity
  • Nanoemulsions Begin to Make a Mark
  • Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
  • Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
  • Recent Advancements in Polymeric Drug Delivery Systems
  • Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
  • Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
  • SLNs in Pulmonary Delivery of Drugs
  • Other Nanocarriers in Pulmonary Delivery
  • Increasing Importance of Gold Nanoparticles in Targeted Drug Administration
  • Gold Nanoparticles Open New Avenues in Combinatorial Cancer Therapy
  • Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities
  • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 and 2023
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • TABLE 3: World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 4: World 7-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World 7-Year Perspective for Embolization Particles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 7: World Novel Drug Delivery Systems (NDDS) Market Analysis of Annual Sales in US$ Million for Years 2020 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 8: USA Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 9: USA 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• CANADA
  • TABLE 10: Canada Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 11: Canada 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• JAPAN
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 12: Japan Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 13: Japan 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• CHINA
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 14: China Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 15: China 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• EUROPE
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 16: Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 17: Europe 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • TABLE 18: Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 19: Europe 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• FRANCE
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 20: France Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: France 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• GERMANY
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 22: Germany Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 23: Germany 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• ITALY
  • TABLE 24: Italy Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 25: Italy 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• UNITED KINGDOM
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 26: UK Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: UK 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• REST OF EUROPE
  • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 29: Rest of Europe 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• ASIA-PACIFIC
  • Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 31: Asia-Pacific 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030
• REST OF WORLD
  • TABLE 32: Rest of World Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Rest of World 7-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2024 & 2030

IV. COMPETITION